Correlation Between Cingulate Warrants and Lumos Pharma
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Lumos Pharma, you can compare the effects of market volatilities on Cingulate Warrants and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Lumos Pharma.
Diversification Opportunities for Cingulate Warrants and Lumos Pharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cingulate and Lumos is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Lumos Pharma go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Lumos Pharma
If you would invest 5.13 in Cingulate Warrants on December 29, 2024 and sell it today you would earn a total of 0.08 from holding Cingulate Warrants or generate 1.56% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Cingulate Warrants vs. Lumos Pharma
Performance |
Timeline |
Cingulate Warrants |
Lumos Pharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Cingulate Warrants and Lumos Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cingulate Warrants and Lumos Pharma
The main advantage of trading using opposite Cingulate Warrants and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.Cingulate Warrants vs. Cingulate | Cingulate Warrants vs. Celularity | Cingulate Warrants vs. NeuroSense Therapeutics Ltd | Cingulate Warrants vs. Dermata Therapeutics Warrant |
Lumos Pharma vs. Shattuck Labs | Lumos Pharma vs. Champions Oncology | Lumos Pharma vs. Century Therapeutics | Lumos Pharma vs. Silo Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |